Status:
COMPLETED
Efficiency and Cost-effectiveness of a Culturally Adopted Lifestyle Intervention Program - the MEDIM Study.
Lead Sponsor:
Region Skane
Collaborating Sponsors:
Lund University
Conditions:
Type 2 Diabetes
Impaired Glucose Tolerance
Eligibility:
All Genders
30-75 years
Phase:
NA
Brief Summary
An increasing proportion of Sweden's population comprises non-European immigrants, who constitute a high risk-population for T2D. Numbering almost 9,000 individuals, Iraqi citizens represent the large...
Detailed Description
In this randomized controlled trial, 308 participants (born in Iraq, living in Malmö, Sweden and at high risk of type 2 diabetes) will be allocated to either a culturally adapted intervention or a con...
Eligibility Criteria
Inclusion
- (1) 30 to 75 years of age
- (2) individuals in the baseline survey diagnosed with prediabetes. OR BMI ≥ 28 kg/m2 OR waist \>=80 cm in females and \>=94cm in males.
Exclusion
- pregnancy, severe mental illness, diabetes, and/or cognitive impairment, current CVD or history of CVD events. CVD includes stroke, angina or myocardial infarction (MI), percutaneous transluminal coronary angioplasty (PTCA), congestive heart failure (CHF), coronary artery bypass graft surgery (CABG), transient ischemic attack (TIA) and peripheral vascular disease (PVD) or other physical disorders that prevent physical exercise.
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT01420198
Start Date
January 1 2015
End Date
June 1 2015
Last Update
October 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Primary Health Care Research, Region Skåne and Lund University
Malmo, Skåne County, Sweden, 20502